NO905012D0 - Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten. - Google Patents

Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.

Info

Publication number
NO905012D0
NO905012D0 NO905012A NO905012A NO905012D0 NO 905012 D0 NO905012 D0 NO 905012D0 NO 905012 A NO905012 A NO 905012A NO 905012 A NO905012 A NO 905012A NO 905012 D0 NO905012 D0 NO 905012D0
Authority
NO
Norway
Prior art keywords
oxacefemer
cefemer
carbacefemer
sulphonyloxy
substituted
Prior art date
Application number
NO905012A
Other languages
English (en)
Other versions
NO905012L (no
NO177348B (no
NO177348C (no
Inventor
Stephen Richard Baker
Chester Sapino Jr
Gregory Paul Roth
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO905012D0 publication Critical patent/NO905012D0/no
Publication of NO905012L publication Critical patent/NO905012L/no
Publication of NO177348B publication Critical patent/NO177348B/no
Publication of NO177348C publication Critical patent/NO177348C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO905012A 1989-11-21 1990-11-20 Fremgangsmåte til fremstilling av et cefalosporin-antibiotikum, samt 3-(fluorsulfonyl)oksy-substituerte cefemer og karbacefemer NO177348C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43976789A 1989-11-21 1989-11-21
US07/603,872 US5245027A (en) 1989-11-21 1990-10-31 3-fluorosulfonyloxyceph-3-em compounds

Publications (4)

Publication Number Publication Date
NO905012D0 true NO905012D0 (no) 1990-11-20
NO905012L NO905012L (no) 1991-05-22
NO177348B NO177348B (no) 1995-05-22
NO177348C NO177348C (no) 1995-08-30

Family

ID=27032165

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905012A NO177348C (no) 1989-11-21 1990-11-20 Fremgangsmåte til fremstilling av et cefalosporin-antibiotikum, samt 3-(fluorsulfonyl)oksy-substituerte cefemer og karbacefemer

Country Status (14)

Country Link
US (2) US5245027A (no)
EP (1) EP0431794A3 (no)
JP (1) JP2964423B2 (no)
KR (1) KR0148488B1 (no)
AU (1) AU637650B2 (no)
CA (1) CA2030361C (no)
FI (1) FI97545C (no)
HU (2) HU213400B (no)
IE (1) IE904191A1 (no)
IL (1) IL96417A (no)
NO (1) NO177348C (no)
NZ (1) NZ236183A (no)
OA (1) OA09329A (no)
RU (2) RU2044738C1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3224279B2 (ja) * 1992-07-27 2001-10-29 大塚化学株式会社 セフエム化合物の製造法
JP4510957B2 (ja) * 1999-09-01 2010-07-28 大塚化学株式会社 セフェム化合物の製造方法
KR100459387B1 (ko) * 2001-10-29 2004-12-03 한동기 인스탄트 돈가스 소스용 조성물 및 레토르트파우치 제품제조방법
JP5443118B2 (ja) * 2009-03-31 2014-03-19 三菱マテリアル株式会社 ビス(フルオロスルホニル)イミド塩の製造方法、ビス(フルオロスルホニル)イミド塩及びフルオロ硫酸塩の製造方法、並びにビス(フルオロスルホニル)イミド・オニウム塩の製造方法
CN102718714B (zh) * 2012-06-26 2014-09-17 天津师范大学 蒽桥联的四齿咪唑盐及其制备方法与应用
EP4295841A3 (en) * 2014-06-06 2024-03-13 The Scripps Research Institute Sulfur (vi) fluoride compounds and their use in click-reaction
JP2017531650A (ja) * 2014-10-08 2017-10-26 ダウ グローバル テクノロジーズ エルエルシー 第1の化合物を第2の化合物にカップリングさせるための方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207327A1 (es) * 1974-02-06 1976-09-30 Lilly Co Eli Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters
US4820816A (en) * 1985-08-02 1989-04-11 President And Fellows Of Harvard College 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
US4855418A (en) * 1988-03-23 1989-08-08 Eli Lilly And Company Process for production of ceophalosporins

Also Published As

Publication number Publication date
NO905012L (no) 1991-05-22
KR0148488B1 (ko) 1998-11-02
CA2030361C (en) 2001-01-30
EP0431794A2 (en) 1991-06-12
IL96417A (en) 1995-03-15
JPH03220195A (ja) 1991-09-27
HUT66487A (en) 1994-11-28
RU2044738C1 (ru) 1995-09-27
KR910009713A (ko) 1991-06-28
US5420269A (en) 1995-05-30
FI905699A0 (fi) 1990-11-19
NO177348B (no) 1995-05-22
IL96417A0 (en) 1991-08-16
CA2030361A1 (en) 1991-05-22
EP0431794A3 (en) 1992-03-25
IE904191A1 (en) 1991-05-22
FI97545B (fi) 1996-09-30
NZ236183A (en) 1992-03-26
FI97545C (fi) 1997-01-10
US5245027A (en) 1993-09-14
FI905699A (fi) 1991-05-22
AU6677090A (en) 1991-05-30
OA09329A (fr) 1992-09-15
HU209309B (en) 1994-04-28
AU637650B2 (en) 1993-06-03
RU2070200C1 (ru) 1996-12-10
JP2964423B2 (ja) 1999-10-18
HU907221D0 (en) 1991-05-28
HU213400B (en) 1997-06-30
NO177348C (no) 1995-08-30
HU9303608D0 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
NO870890L (no) FremgangsmŸte for fremstilling av aromatiske 2-aminoalkyl-1,2-benzoisothiazol-3-(2h)-on-1,1-dioxyd-derivater.
NO914751L (no) N,o-sulfaterte heparosaner, fremgangsmaate ved fremstilling av dem og farmasoeytiske blandinger inneholdende dem
NO167747C (no) Fremgangsmaate for fremstilling av tetra-n-acetyl-kitotetraose, penta-n-acetyl-kitopentaose og heksa-n-acetyl-kitoheksaose ved delvis hydrolyse av kitin.
NO871602L (no) 1-hydroksy-2-pyridoner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem samt ved fremstillingen av 1-hydroksy-2-pyridoner dannede mellomprodukter.
NO864241L (no) Fremgangsmaate ved bleking av cellulosemasse eller fraksjon derav, anlegg til bruk ved gjennomfoeringen av fremgangsmaaten og skruepresse, saerlig til bruk ved fremgangsmaaten henholdsvis i anlegget.
NO904471D0 (no) Fremgangsmaate for fremstilling av partikkelformig titandioxyd.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
NO905444L (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO905012D0 (no) Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.
NO884770D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenoler, og mellomprodukt for anvendelse ved denne.
NO960307D0 (no) Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
EP0421216A3 (en) Process for the preparation of 2,4, resp. 2,6 dihalo-aniline
NO881487L (no) Fremgangsmaate til fremstilling av alfa-(1-metyletyl)-3,4-dimetoksybenzen-xen-acetonitril, samt mellomprodukt som dannes ved fremgangsmaaten.
NO903741D0 (no) Fremgangsmaate ved fremstilling av emballasje.
EP0663207A3 (en) Bamboo salt manufacturing process.
NO905244D0 (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO913069L (no) Fremgangsmaate ved bekjempelse av granbarkbiller.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO870889L (no) FremgangsmŸte for fremstilling av aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater.
NO901454L (no) Fremgangsmaate til fremstilling av n-metyl-3,4-dimetoksyfenyletylamin.